Elanco Animal Health (ELAN) Change in Cash (2017 - 2026)
Elanco Animal Health (ELAN) posted Change in Cash of -$117.0 million for Q1 2026, down 392.5% sequentially from $40.0 million in Q4 2025, and down 715.79% YoY from $19.0 million in Q1 2025.
Elanco Animal Health (ELAN) Change in Cash (2017 - 2026) Analysis & Trends
Elanco Animal Health has reported Change in Cash for 10 years, with the latest figure at -$117.0 million in Q1 2026.
- Quarterly Change in Cash fell 715.79% year-over-year to -$117.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$59.0 million (down 141.55% YoY) and the FY2025 annual result came in at $77.0 million, down 33.62% from the prior year.
- Change in Cash retreated to -$117.0 million in Q1 2026 per ELAN's latest filing, from $40.0 million in the prior quarter.
- Over five years, Change in Cash peaked at $165.0 million in Q2 2022 and troughed at -$296.0 million in Q1 2022.
- A 5-year average of -$12.4 million and a median of -$7.0 million in 2024 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2022 and 2024: Change in Cash sank 3388.89% in 2022, then surged 3600.0% in 2024.
- Over 5 years, Change in Cash stood at -$115.0 million in 2022, then surged by 85.22% to -$17.0 million in 2023, then dropped by 29.41% to -$22.0 million in 2024, then surged by 281.82% to $40.0 million in 2025, then slumped by 392.5% to -$117.0 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered -$117.0 million, $40.0 million, and -$34.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.31 Bn | 39.66 Bn | 2.15 Bn | -86.00 Mn |
| 3 | Zoetis | 31.65 Bn | 29.98 Bn | 1.05 Bn | -465.00 Mn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.18 Bn | 19.52 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.82 Bn | 17.94 Bn | 1.46 Bn | -915.70 Mn |
| 7 | Neurocrine Biosciences | 15.70 Bn | 15.31 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 102.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn | 159.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 102.00 Mn |
| Mar 31, 2026 | -117.00 Mn |
| Dec 31, 2025 | 40.00 Mn |
| Sep 30, 2025 | -34.00 Mn |
| Jun 30, 2025 | 52.00 Mn |
| Mar 31, 2025 | 19.00 Mn |
| Dec 31, 2024 | -22.00 Mn |
| Sep 30, 2024 | 74.00 Mn |
| Jun 30, 2024 | 71.00 Mn |
| Mar 31, 2024 | -7.00 Mn |
| Dec 31, 2023 | -17.00 Mn |
| Sep 30, 2023 | 2.00 Mn |
| Jun 30, 2023 | 49.00 Mn |
| Mar 31, 2023 | -27.00 Mn |
| Dec 31, 2022 | -115.00 Mn |
| Sep 30, 2022 | -47.00 Mn |
| Jun 30, 2022 | 165.00 Mn |
| Mar 31, 2022 | -296.00 Mn |
| Dec 31, 2021 | 185.00 Mn |
| Sep 30, 2021 | -127.00 Mn |